Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication in the lung

American Journal of Respiratory and Critical Care Medicine

Volumn 155, Issue 3, 1997, Pages 996-1003

  Nakata, Koh ^b   Rom, William N ^b   Honda, Yoshihiro ^b   Condos, Rany ^b   Kanegasaki, Shiro ^b   Cao, Yunzhen ^b   Weiden, Michael ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120; TUMOR NECROSIS FACTOR ALPHA; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID SEQUENCE; ARTICLE; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN TISSUE; LONG TERMINAL REPEAT; LUNG LAVAGE; LUNG TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; OPPORTUNISTIC INFECTION; PHYLOGENY; PRIORITY JOURNAL; VIRUS MUTATION; VIRUS PARTICLE; VIRUS REPLICATION;

EID: 0030944536     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.155.3.9117038     Document Type: Article

References (35)

1. Garay, S. 1996. Tuberculosis and the human immunodeficiency virus infection. In W. N. Rom and S. Garay, editor. Tuberculosis. Little, Brown, Boston. 443-466.
2. Selwyn, P. A., D. Hartel, V. A. Lewis, E. E. Schoenbaum, S. H. Vermund, R. S. Klein, A. T. Walker, and G. H. Freidland. 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N. Engl. J. Med. 320:545-550.
3. Fischl, M. A, R. E. Uttamchandani, and G. L. Daiko. 1992. An outbreak of tuberculosis caused by multiple-drug-resistant tubercle bacilli among patients with HIV infection. Ann. Intern. Med. 117:177-183.
4. Park, M. M., A. Davis, N. Schluger, H. Cohen, and W. N. Rom. 1996. Outcome of MDR-TB patients, 1983-1993: prolonged survival with appropriate therapy. Am. J. Respir. Crit. Care Med. 153:317-324.
5. Whalen, C., C. R. Horsburgh, D. Hom, C. Lahart, M. Simberkoff, and J. Ellner. 1995. Accelerated course of human immnodeficiency virus infection after tuberculosis. Am. J. Respir. Crit. Care Med. 151:129-135.
6. World Health Organization Report on the TB Epidemic. 1994. WHO/TB 94:177.
7. Law, K. F., M. Weiden, T. Harkin, K. Tchou-Wong, C. Chi, and W. N. Rom. 1996. Increased release of IL-1β, IL-6, and TNF-α by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 153:799-804.
8. Israel-Biet, D., J. Cadranel, K. Beldjord, J. Andrieu, A. Jeffrey, and P. Even. 1991. Tumor necrosis factor production in HIV-seropositive subjects: relationship with lung opportunistic infections and HIV expression in alveolar macrophages. J. Immunol. 147:490-494.
9. Law, K. F., J. Jagirdar, M. Weiden, M. Bodkin, and W. N. Rom. 1996. Tuberculosis in HIV-positive patients: cellular response and immune activation in the lung. Am. J. Respir. Crit. Care Med. 153:1377-1384.
10. Zhang, Y., M. Broser, and W. N. Rom. 1994. Activation of the interleukin-6 gene by Mycobacterium tuberculosis or lipopolysaccharide is mediated by NF-IL6 and NF-κB. Proc. Natl. Acad. Sci. U.S.A. 91:2225-2229.
11. Zhang, Y., and W. N. Rom. 1993. Regulation of the interleukin-1β gene by mycobacterial components and lipopolysaccharide is mediated by two NF-IL6-like motifs. Mol. Cell. Biol. 13:3831-3837.
12. Dun, E., W. Maury, T. Folks, A. Fauci, and A. Rabson. 1989. Tumor necrosis factor a activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. U.S.A. 86:5974-5978.
13. Bernstein, M. S., S. E. Tong-Starksen, and R. M. Locksley. 1991. Activation of human monocyte-derived macrophages with lipopolysaccharide decreases human immunodeficiency virus replication at the level of gene expression. J. Clin. Invest. 88:540-545.
14. Goletti, A., P. Kinter, P. Biswas, S. Bende, G. Poli, and A. Fauci. 1995. Effects of cellular differentiation on cytokine-induced expression on human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J. Virol. 69:2540-2546.
15. Rich, E., I. Chen, J. Zack, M. Leonard, and W. O'Brien. 1992. Increased susceptibility of differentiated mononuclear phagocytes to productive infection with human immunodeficiency virus-1. J. Clin. Invest. 89:176-183.
16. Shattock, R. J., J. Friedland, and G. Groffin. 1994. Phagocytosis of Mycobacterium tuberculosis modulates human immunodeficiency virus replication in human monocytic cells. J. Gen. Virol. 75:849-856.
17. Zhang, Y., K. Nakata, M. Weiden, and W. N. Rom. 1995. Mycobacterium tuberculosis enhances HIV-1 replication by transcriptional activation at the long terminal repeat. J. Clin. Invest. 95:2324-2331.
18. Lederman, M., D. Georges, D. Kusner, P. Mudido, C. Giam, and Z. Toossi. 1994. Mycobacterium tuberculosis and its purified protein derivatie activate expression of human immunodeficiency virus. J. Acquir. Immun. Deficiency Syndrome 7:727-733.
19. Rennard, S. I., G. Basset, D. Lecossier, K. O'Donnell, P. Pinkston, P. Martin, and R. Crystal. 1986. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
20. Nakata, K., M. Weiden, T. Harkin, D. Ho, and W. N. Rom. 1995. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1 infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Mol. Med. 1:744-757.
21. Berenguer, J., M. Santiago, F. Laguna, T. Vicente, M. Adrados, A. Onega, J. Gonzalez-La Hoz, and E. Bouza. 1992. Tuberculosis meningitis in patients infected with the human immunodeficiency virus. N. Engl. J. Med. 326:668-672.
22. Goleti, D., D. Weissman, R. Jackson, N. Graham, D. Vlahov, R. Klein, S. Munsiff, L. Ortona, R. Cauda, and A. Fauci. 1996. Effect of Mycobacterium tuberculosis on HIV replication: role of immune activation. J. Immunol. 157:1271-1278.
23. Donovan, R. M., C. Bush, N. Markowitz, D. Baxa, and L. Saravolatz. 1996. Changes in virus load markers during AIDS-associated opportunistic diseases in human immunodeficiency virus-infected persons. J. Infect. Dis. 174:401-403.
24. Peterson, P. K., G. Gekker, C. C. Chao, S. Hu, C. Edelman, H. H. Balfour, and J. Verhoef. 1992. Human cytomegalovirus-stimulated peripheral blood mononuclear cells induce HIV-1 replication via a tumor necrosis factor-α-mediated mechanism. J. Clin. Invest. 89: 574-580.
25. Ho, D. D. 1992. HIV-1 viremia and influenza. Lancet 339:1549.
26. Lu, W., and D. Israel-Biet. 1993. Virion concentration in broncnoalveolar lavage fluids of HIV-infected patients. Lancet 342:298.
27. Stanley, S. K., M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci. 1996. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type I. N. Engl. J. Med. 334:1222-1230.
28. Denis, M., and E. Ghadirian. 1994. Interaction between Mycobacterium avium and human immunodeficiency virus type 1 (HIV-1) in bronchoalveolar macrophages of normal and HIV-1-infected subjects. Am. J. Respir. Cell Mol. Biol. 11:487-495.
29. Sierra-Madero, J., Z. Toossi, D. Hom, C. Finegan, E. Hoenig, and E. Rich. 1994. Relationship between load of virus in alveolar macrophages from human immunodeficiency virus type 1-infected persons, production of cytokines, and clinical status. J. Infect. Dis. 169:18-27.
30. Toossi, Z., J. Sierra-Madero, R. Blinkhorn, M. Mettler, and E. Rich. 1993. Enhanced susceptibility of blood monocytes from patients with pulmonary tuberculosis to productive infection with human immunodeficiency virus type 1. J. Exp. Med. 177:1511-1516.
31. Shioda, T., S. Oka, S. Ida, K. Nokihara, H. Toriyoshi, S. Mori, Y. Takebe, S. Kimura, K. Shimada, and Y. Nagai. 1994. A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus. J. Virol. 68:7689-7696.
32. Stamatatos, L., and C. Cheng-Meye. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity, host range, and syncytium-forming ability. J. Virol. 67:5635-5639.
33. Donaldson, Y., J. Bell, E. Holmes, E. Hughes, H. Brown, and P. Simmons. 1994. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J. Virol. 68:5991-6005.
34. Itescu, S., P. F. Simonelli, R. J. Winchester, and H. S. Ginsberg. 1994. Human immunodeficiency virus type 1 strains in the lungs of infected individuals evolve independently from those in the peripheral blood and are highly conserved in the C-terminal region of the envelope V3 loop. Proc. Natl. Acad. Sci. U.S.A. 91:11378-11382.
35. Hirschtick, R., J. Glassroth, M. Jordan, T. Wilcosky, J. Wallace, P. Kvale, N. Markowitz, M. Rosen, B. Mangura, and P. Hopewell. 1995. Bacterial pneumonia in persons infected with the human immunodeficiency virus. N. Engl. J. Med. 333:845-851.